Skip to main content
All lobbying filings

PRIME THERAPEUTICS

Lobbying for PRIME THERAPEUTICS

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate · $100,000.00 expenses · posted Jul 16, 2025

Official filing document

 Bills named in this filing 8
  • HR 2214
    DRUG Act
  • S 891
    Bipartisan Health Care Act
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S 832
    EPIC Act of 2025
  • HR 10445
    Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
  • HR 5378
    Lower Costs, More Transparency Act
  • S 1339
    Pharmacy Benefit Manager Reform Act
  • HR 1
    Lower Energy Costs Act
 Lobbying activity 3
Health Issues

H.R.2214: The DRUG Act, provisions related to PBM compensation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. S.526 Pharmacy Benefit Manger Transparency Act of 2025, provisions related to transparency and pharmacy and PBM compensation. S.1339 PBM Reform Act (118th Congress): provisions related to PBM compensation.

Medicare/Medicaid

S.832: EPIC Act, provisions on eligibility for Medicare drug price negotiation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. H.R.1: The One Big Beautiful Bill (House version), provisions on PBM transparency, audit rights and payments.

Trade (domestic/foreign)

Tariffs on pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem